Literature DB >> 14689810

Pharmacoeconomic research.

Maarten J Postma1.   

Abstract

Efficacy and safety are crucial considerations in judging drugs, for example, whether or not to include them in a local formulary. More and more, pharmacoeconomic aspects are becoming of additional importance. How should we interpret such pharmacoeconomic studies? To enhance accurate interpretation of such studies among our readership, we present the basic concepts of pharmacoeconomics in this commentary.

Mesh:

Year:  2003        PMID: 14689810     DOI: 10.1023/b:phar.0000006525.10662.50

Source DB:  PubMed          Journal:  Pharm World Sci        ISSN: 0928-1231


  3 in total

Review 1.  Economic evaluation of influenza vaccination. Assessment for The Netherlands.

Authors:  M J Postma; J M Bos; M van Gennep; J C Jager; R Baltussen; M J Sprenger
Journal:  Pharmacoeconomics       Date:  1999       Impact factor: 4.981

2.  [Pharmaco-economic evaluation of mandatory HIV-screening in pregnancy; a cost-efficacy analysis in Amsterdam].

Authors:  M J Postma; J A van den Hoek; E J Beck; B Heeg; J C Jager; R A Coutinho
Journal:  Ned Tijdschr Geneeskd       Date:  2000-04-15

3.  [Screening for asymptomatic Chlamydia trachomatis infection in pregnancy; cost-effectiveness favorable at a minimum prevalence rate of 3% or more].

Authors:  M J Postma; A Bakker; R Welte; J E van Bergen; J A van den Hoek; L T de Jong-van den Berg; J C Jager
Journal:  Ned Tijdschr Geneeskd       Date:  2000-12-02
  3 in total
  1 in total

1.  Applying health technology assessment to pharmaceutical care: pitfalls and future directions.

Authors:  Steven Simoens; Gert Laekeman
Journal:  Pharm World Sci       Date:  2005-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.